Clinical Cardiology Alert – May 1, 2003
May 1, 2003
View Issues
-
Late-Breaking Trials
Editors Note: The following reports from the annual scientific sessions of the American College of Cardiology held March 30 to April 2, 2003, were obtained by handwritten notes, press releases, and news reports. -
Aldosterone Blockade: Another Winner
Synopsis: When RALES and EPHESUS are considered together, one clearly can recommend the use of an aldosterone receptor blocker for all very ill patients with congestive heart failure and significant LV dysfunction, whether or not related to acute myocardial infarction. -
Pharmacology Watch: Counterfeit Procrit Uncovered by FDA Surveillance
In one of the more bizarre stories of the year, the FDA has uncovered files of counterfeit Procrit (epoetin alfaJohnson & Johnson) in routine surveillance. To make matters worse, the fake vials have been contaminated with bacteria and many contain no active ingredient. -
Clinical Briefs in Primary Care Supplement